In a recent @thrombosis-update.bsky.social article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance.
Read more here:
sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
Posts by Thrombosis Update
New article in @thrombosis-update.bsky.social
Researchers suggest that patients with multiple or high-titer antiphospholipid antibodies face a seven to 21-fold increased risk of severe mental illness. #APS #TruUpdate
@lucynortcd.bsky.social
New article in @thrombosis-update.bsky.social
"A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks"
Read more: here:www.sciencedirect.com/science/article/pii/S266...
A new study in @thrombosis-update.bsky.social reveals that #VTE -related deaths are over three times higher in LA County jails than in the general population. #HealthEquity #PublicHealth #Incarceration
Read more here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
New article in @thrombosis-update.bsky.social 👇
Findings from a phase 2 trial show that Auxora™ may help patients with severe #COVID19 by reducing D-dimer levels.
@lucynortcd.bsky.social #TruJournal
Read more here:
www.sciencedirect.com/science/arti...
A new study in #ThrombosisUpdate reveals what patients value in thrombosis care!
Clear info & respectful relationships are key to satisfaction, but virtual options and affordable medication are areas for improvement.
@lucynortcd.bsky.social
Read more here:
www.sciencedirect.com/science/arti...
A new study in @thrombosis-update.bsky.social shows that freezing plasma samples doesn't significantly affect #thrombin generation measurements over long-term storage (up to 2 years at -80°C).
@lucynortcd.bsky.social #TruJournal
Read more here:
www.sciencedirect.com/science/arti...
A new multicenter study in @thrombosis-update.bsky.social from Colombia characterizes anticoagulation reversal practices, revealing bleeding as the primary indication and warfarin as the most common anticoagulant.
@lucynortcd.bsky.social #TruJournal
Full text:
www.sciencedirect.com/science/arti...
In this @thrombosis-update.bsky.social article, the authors found that underdosing #DOACs for nonvalvular atrial fibrillation is linked to higher risks of stroke and major bleeding compared to on-label dosing.
Read more here: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
New study in @thrombosis-update.bsky.social reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients.
Read more here: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
A new case study in @thrombosis-update.bsky.social
on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery.
Read more here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
What goes into deciding about #Antithrombotic therapy for #cancer patients at end of life? 🤔
The #SERENITY project is finding out!
Read more here in @thrombosis-update.bsky.social
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
New meta-analysis in @thrombosis-update.bsky.social
on aspirin for infective endocarditis reveals mixed results for preventing embolic events.
Read more here: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
Why is #VTE mortality falling in Finland🇫🇮 despite soaring #PE incidence? 📉
A nationwide registry study in @thrombosis-update.bsky.social reveals key trends, including stable DVT rates & a surge in diagnostic imaging.
Important and🗝️ findings for #VTE epidemiology.
@lucynortcd.bsky.social
Safe #PE treatment for #cancer patients?
Ultrasound-guided thrombolysis #CDT shows promise! New study in @thrombosis-update.bsky.social found similar low bleeding rates in cancer & non-cancer patients.
Read more here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
Don’t miss out! 🚨 Early registration for #ISTH2025 closes April 22! Register now to score the lowest rates and guarantee your spot at the premier event for cutting-edge science, expert insights & unforgettable connections.
Lock in➡️https://www.isth2025.org/
From molecular mechanisms to clinical breakthroughs,
@thrombosis-update.bsky.social covers it all!
Submit your original research, reviews, or case reports today.
www.sciencedirect.com/journal/thro...
@lucynortcd.bsky.social #TruJournal
Is there a better way to predict pulmonary thromboembolism #PTE mortality? 🤔
New research in @thrombosis-update.bsky.social says RV/LV ratio on #CTPA might be the key.
Find out more:
how:www.sciencedirect.com/science/article/pii/S266...
#TruJournal
Critically ill #COVID19 patients on heparin?
New study in @thrombosis-update.bsky.social reveals aPTT & anti-Xa monitoring often clash, impacting bleeding risk. Switching to anti-Xa guidance?
Could mean fewer #Bleeding events.
Read more here:
www.sciencedirect.com/science/arti...
One size doesn't fit all: DOACs for VTE in inherited thrombophilia need tailored approaches.
New findings in @thrombosis-update.bsky.social emphasize patient-centered care.
Read the full text here:
www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #TruJournal
This new study in @thrombosis-update.bsky.social investigates how multimorbidity and its severity, along with specific disease clusters, relate to the risk of #VTE.
@lucynortcd.bsky.social #TruJournal
Read more here at: www.sciencedirect.com/science/arti...
A study in @thrombosis-update.bsky.social the authors found that rosuvastatin did not prevent thrombus formation nor speed up resolution.
#VTE #TruJournal
Read the full article to learn morewww.sciencedirect.com/science/article/pii/S266...
@lucynortcd.bsky.social
@simonnoble.bsky.social
This recent study in @thrombosis-update.bsky.social compared the safety and effectiveness of using a reduced apixaban lead-in vs. full lead-in dosing in #VTE.
Read more here at: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social #ThrJournal
The recent @thrombosis-update.bsky.social paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research.
#ThrJournal @lucynortcd.bsky.social
www.sciencedirect.com/science/arti...
Here is the editorial commentary by @lucynortcd.bsky.social and Dr. Papadakis on the article by Mateo et al. in
@thrombosis-update.bsky.social in which ther authors presented the data from the TESEO registry.
Read more here: www.sciencedirect.com/science/arti...
Tissue factor (TF aka F3) is the main initiator of blood coagulation. In this new @thrombosis-update.bsky.social study, the authors determined the molecular epidemiology and the importance of #F3 variants for incident #VTE
Read more: www.sciencedirect.com/science/arti...
@lucynortcd.bsky.social